Pasithea Therapeutics Corp.
(NASDAQ : KTTA)

( )
KTTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.82%51.820.9%$2134.02m
JNJJohnson & Johnson -0.10%164.200.7%$1380.71m
MRKMerck & Co., Inc. 0.27%73.380.7%$1046.21m
BMYBristol-Myers Squibb Co. -0.07%57.551.0%$830.65m
LLYEli Lilly & Co. -0.03%244.251.1%$718.99m
ABBVAbbVie, Inc. 0.15%122.071.9%$628.46m
AZNAstraZeneca Plc 0.13%55.201.0%$309.88m
NVSNovartis AG -0.43%81.000.2%$178.09m
GSKGlaxoSmithKline Plc 0.22%42.770.2%$162.24m
DRNADicerna Pharmaceuticals, Inc. 0.00%38.000.3%$157.34m
VTRSViatris, Inc. 1.37%12.600.0%$142.99m
BFRIBiofrontera, Inc. 4.49%5.120.0%$137.81m
RPRXRoyalty Pharma Plc 0.00%39.160.1%$121.97m
RGENRepligen Corp. 0.00%266.036.7%$99.58m
NVONovo Nordisk A/S 0.34%113.810.1%$88.92m

Company Profile

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah in May, 2020 and is headquartered in Miami Beach, FL.